Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Larson

Showing results (651-660 of 798) with videos related to

Pageof 80
Sort By:
Nanomaterials (Basel, Switzerland)|March 25, 2017
Distribution of Iron Oxide Core-Titanium Dioxide Shell Nanoparticles in VX2 Tumor Bearing Rabbits Introduced by Two Different Delivery ModalitiesTamer Refaat, Derek West, Samar El Achy, et al.
Archives of Sexual Behavior|August 10, 2016
Female Sexual Function Index Short Version: A MsFLASH Item Response AnalysisJanet S Carpenter, Salene M W Jones, Christina R Studts, et al.
Anesthesia and Analgesia|February 9, 2012
Noninvasive autoregulation monitoring in a swine model of pediatric cardiac arrestJennifer K Lee, Zeng-Jin Yang, Bing Wang, et al.
Journal of the American Heart Association|August 22, 2014
Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal womenFarnaz Azarbal, Marcia L Stefanick, Elena Salmoirago-Blotcher, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 2025
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of OriginGeffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, et al.
Blood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Scientific Reports|April 14, 2021
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) settingAnn L Oberg, Ethan P Heinzen, Xiaonan Hou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.
Molecular Carcinogenesis|April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer riskEllen L Goode, Kristin L White, Robert A Vierkant, et al.
Pageof 80

Showing results (651-660 of 798) with videos related to

Sort By:
Pageof 80
Nanomaterials (Basel, Switzerland)|March 25, 2017
Distribution of Iron Oxide Core-Titanium Dioxide Shell Nanoparticles in VX2 Tumor Bearing Rabbits Introduced by Two Different Delivery ModalitiesTamer Refaat, Derek West, Samar El Achy, et al.
Archives of Sexual Behavior|August 10, 2016
Female Sexual Function Index Short Version: A MsFLASH Item Response AnalysisJanet S Carpenter, Salene M W Jones, Christina R Studts, et al.
Anesthesia and Analgesia|February 9, 2012
Noninvasive autoregulation monitoring in a swine model of pediatric cardiac arrestJennifer K Lee, Zeng-Jin Yang, Bing Wang, et al.
Journal of the American Heart Association|August 22, 2014
Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal womenFarnaz Azarbal, Marcia L Stefanick, Elena Salmoirago-Blotcher, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 2025
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of OriginGeffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, et al.
Blood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Scientific Reports|April 14, 2021
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) settingAnn L Oberg, Ethan P Heinzen, Xiaonan Hou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.
Molecular Carcinogenesis|April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer riskEllen L Goode, Kristin L White, Robert A Vierkant, et al.
Pageof 80